A cross-sectional study to evaluate the effectiveness of XALKORI Therapeutic Management Guide among physician prescribing XALKORI in Europe

02/09/2014
02/07/2024
EU PAS number:
EUPAS7389
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

A8081049_PROTOCOL_Crizotinib Physician Survey_25March2014

English (958.16 KB - PDF) View document
Updated protocol

A8081049_PROTOCOL AMENDMENT 2_Crizotinib Physician Survey_30 March 2015 Clean_register

First published: 22/02/2024
English (346.74 KB - PDF) View document
Study results
Study results

Crizotinib A8081049 NI Study Report

English (6.54 MB - PDF) View document
Study report
Other information